Hold Fortis Healthcare, may test Rs 210-215: Vijay Chopra

Vijay Chopra of enochventures.com told CNBC-TV18, "My sense is that there are not going to be any major fireworks in Fortis Healthcare, although there are few good news around this company. Delhi High Court has given them approval to sell the stake. So probably this can propel the stock to about Rs 210-215. But I do not see any Rs 250 kind of a level happening. So that is quite possible that we see Rs 210-220 odd levels happening on the stock. Positive news all over, so definitely hold on to the stock as of now and probably one can wait for another Rs 10-15 and then cash out."

At 14:46 hrs Fortis Healthcare was quoting at Rs 199.70, up Rs 4.80, or 2.46 percent.

The share touched its 52-week high Rs 230.90 and 52-week low Rs 170 on 03 May, 2017 and 09 November, 2016, respectively.